2-233256125-G-C
Position:
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 0P and 4B. BS2
The NM_030803.7(ATG16L1):āc.139G>Cā(p.Asp47His) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000123 in 1,461,734 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: not found (cov: 32)
Exomes š: 0.000012 ( 0 hom. )
Consequence
ATG16L1
NM_030803.7 missense
NM_030803.7 missense
Scores
7
6
5
Clinical Significance
Conservation
PhyloP100: 9.07
Genes affected
ATG16L1 (HGNC:21498): (autophagy related 16 like 1) The protein encoded by this gene is part of a large protein complex that is necessary for autophagy, the major process by which intracellular components are targeted to lysosomes for degradation. Defects in this gene are a cause of susceptibility to inflammatory bowel disease type 10 (IBD10). Several transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Jun 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -4 ACMG points.
BS2
High AC in GnomAdExome4 at 18 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
ATG16L1 | NM_030803.7 | c.139G>C | p.Asp47His | missense_variant | 2/18 | ENST00000392017.9 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
ATG16L1 | ENST00000392017.9 | c.139G>C | p.Asp47His | missense_variant | 2/18 | 1 | NM_030803.7 | P3 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 genomes
Cov.:
32
GnomAD3 exomes AF: 0.00000802 AC: 2AN: 249348Hom.: 0 AF XY: 0.00000739 AC XY: 1AN XY: 135272
GnomAD3 exomes
AF:
AC:
2
AN:
249348
Hom.:
AF XY:
AC XY:
1
AN XY:
135272
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000123 AC: 18AN: 1461734Hom.: 0 Cov.: 30 AF XY: 0.00000963 AC XY: 7AN XY: 727152
GnomAD4 exome
AF:
AC:
18
AN:
1461734
Hom.:
Cov.:
30
AF XY:
AC XY:
7
AN XY:
727152
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Cov.: 32
GnomAD4 genome
Cov.:
32
ExAC
AF:
AC:
1
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 25, 2022 | The c.139G>C (p.D47H) alteration is located in exon 2 (coding exon 2) of the ATG16L1 gene. This alteration results from a G to C substitution at nucleotide position 139, causing the aspartic acid (D) at amino acid position 47 to be replaced by a histidine (H). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Benign
.;T;T;.;T;.;.;.
Eigen
Pathogenic
Eigen_PC
Pathogenic
FATHMM_MKL
Pathogenic
D
M_CAP
Benign
D
MetaRNN
Uncertain
D;D;D;D;D;D;D;D
MetaSVM
Benign
T
MutationAssessor
Uncertain
M;M;.;M;.;.;M;.
MutationTaster
Benign
D;D;D;D;D
PrimateAI
Pathogenic
T
PROVEAN
Benign
N;N;D;N;D;N;N;N
REVEL
Uncertain
Sift
Uncertain
D;D;D;D;.;D;D;D
Sift4G
Uncertain
D;D;D;D;D;D;D;D
Polyphen
1.0
.;D;.;D;.;.;D;.
Vest4
MutPred
Loss of ubiquitination at K45 (P = 0.0418);Loss of ubiquitination at K45 (P = 0.0418);Loss of ubiquitination at K45 (P = 0.0418);Loss of ubiquitination at K45 (P = 0.0418);Loss of ubiquitination at K45 (P = 0.0418);Loss of ubiquitination at K45 (P = 0.0418);Loss of ubiquitination at K45 (P = 0.0418);Loss of ubiquitination at K45 (P = 0.0418);
MVP
MPC
1.7
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at